Vai direttamente al contenuto

Urologia

Gestione e ottimizzazione dell’emostasi

Farmaci antifibrinolitici

Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial. (apre una nuova finestra)

Crescenti A, Borghi G, Bignami E, Bertarelli G, Landoni G, Casiraghi GM, Briganti A, Montorsi F, Rigatti P, Zangrillo A.

Fonte‎: BMJ 2011;343:d5701.

Indicizzato‎: PubMed 22012809

https://www.ncbi.nlm.nih.gov/pubmed/22012809 (apre una nuova finestra)

Tranexamic acid in patients undergoing noncardiac surgery. (apre una nuova finestra)

Devereaux PJ, Marcucci M, Painter TW, Conen D, Lomivorotov V, Sessler DI, Chan MTV, Borges FK, Martínez-Zapata MJ, Wang CY, Xavier D, Ofori SN, Wang MK, Efremov S, Landoni G, Kleinlugtenbelt YV, Szczeklik W, Schmartz D, Garg AX, Short TG, Wittmann M, Meyhoff CS, Amir M, Torres D, Patel A, Duceppe E, Ruetzler K, Parlow JL, Tandon V, Fleischmann E, Polanczyk CA, Lamy A, Astrakov SV, Rao M, Wu WKK, Bhatt K, de Nadal M, Likhvantsev VV, Paniagua P, Aguado HJ, Whitlock RP, McGillion MH, Prystajecky M, Vincent J, Eikelboom J, Copland I, Balasubramanian K, Turan A, Bangdiwala SI, Stillo D, Gross PL, Cafaro T, Alfonsi P, Roshanov PS, Belley-Côté EP, Spence J, Richards T, VanHelder T, McIntyre W, Guyatt G, Yusuf S, Leslie K; POISE-3 Investigators

Fonte‎: N Engl J Med. 2022;386(21):1986-97.

Indicizzato‎: PubMed 35363452

DOI‎: 10.1056/NEJMoa2201171

https://pubmed.ncbi.nlm.nih.gov/35363452/ (apre una nuova finestra)

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. (apre una nuova finestra)

Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K.

Fonte‎: Cochrane Database Syst Rev 2011;(3):CD001886.

Indicizzato‎: PubMed 21412876

DOI‎: 10.1002/14651858.CD001886.pub4

https://www.ncbi.nlm.nih.gov/pubmed/21412876 (apre una nuova finestra)

Tranexamic acid reduces blood loss during percutaneous nephrolithotomy: a prospective randomized controlled study. (apre una nuova finestra)

Kumar S, Randhawa MS, Ganesamoni R, Singh SK.

Fonte‎: J Urol 2013;189(5):1757-61.

Indicizzato‎: PubMed 23123376

DOI‎: 10.1016/j.juro.2012.10.115

https://www.ncbi.nlm.nih.gov/pubmed/23123376 (apre una nuova finestra)

Fattore VII attivato ricombinante (rFVIIa)